15th International Symposium on Minimal Residual Cancer
“This international meeting is a fantastic opportunity to gather for three days and share many updated aspects concerning the use of liquid biopsies in cancer patients. Moreover, this meeting covers many new developments of liquid biopsy for clinical implementation, with some specific focuses on the role of liquid biopsy in treatment decision making both for immuno-oncology and targeted therapies. Moreover, special sessions will be dedicated to the new aspects of minimal residual disease detection, early detection and screening cancers, and monitoring disease by blood sampling for tracking resistance mechanisms to different therapeutic.
The congress will include also more fundamental and translational presentations on different liquid biopsy components (Circulating Tumor Cells, exosomes, miRNA and circulating free DNA). Additionnally the perspective of liquid biopsy for the next few years will be presented. The 2025 meeting in Nice is supported by the European Liquid Biopsy Society (ELBS) and the new Institut RespirERA created in Nice (IHU RespirERA).” – ISMRC
Location
Nice, France
Date
May 7 - 9 2025
ANGLE attendees
Request a meeting with the ANGLE team at the ISMRC 2025.
Rob Hollifield
Sales Manager - Product Sales
Rob is a Sales Manager at ANGLE, taking care of direct customers and Distributors across the European markets. With 30 years of experience in clinical diagnostics, in both scientific and commercial roles, Rob has built his career around liquid biopsy and continues to share his expertise with our clinical and research partners.
Taj Dhaliwal
EMEA Biopharma Partnering Lead
Working within ANGLE’s Biopharma Services team, Taj is focused on UK, Europe and ROW (ex-US) markets. With a comprehensive career spanning over 20 years in the life sciences and pharmaceutical industry, Taj has amassed a wealth of experience and expertise across numerous sectors.
Rob Hollifield
Sales Manager - Product Sales
Rob is a Sales Manager at ANGLE, taking care of direct customers and Distributors across the European markets. With 30 years of experience in clinical diagnostics, in both scientific and commercial roles, Rob has built his career around liquid biopsy and continues to share his expertise with our clinical and research partners.
Taj Dhaliwal
EMEA Biopharma Partnering Lead
Working within ANGLE’s Biopharma Services team, Taj is focused on UK, Europe and ROW (ex-US) markets. With a comprehensive career spanning over 20 years in the life sciences and pharmaceutical industry, Taj has amassed a wealth of experience and expertise across numerous sectors.